Clinical Trial Update: A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer Who Are Having Hormone Therapy [Phase 3]

View source ↗

Summary

This is a Phase 3 trial update evaluating fezolinetant for reducing hot flashes in women with breast cancer on hormone therapy; the study is currently active bu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hot Flashes

Drugs mentioned

• Fezolinetant (fezolinetant)

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Hot Flashes | Phase 3 | Status: ACTIVE_NOT_RECRUITING